{"id":"https://openalex.org/W1992336722","doi":"https://doi.org/10.1016/0014-2999(95)00693-1","title":"\u03c3 Receptor antagonists block the development of sensitization to cocaine","display_name":"\u03c3 Receptor antagonists block the development of sensitization to cocaine","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W1992336722","doi":"https://doi.org/10.1016/0014-2999(95)00693-1","mag":"1992336722","pmid":"https://pubmed.ncbi.nlm.nih.gov/8838447"},"language":"en","primary_location":{"id":"doi:10.1016/0014-2999(95)00693-1","doi":"https://doi.org/10.1016/0014-2999(95)00693-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(95)00693-1","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009599515","display_name":"Hiroshi Ujike","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hiroshi Ujike","raw_affiliation_strings":["Department of Neuropsychiatry, Okayama University Medical School, Japan","Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, Okayama University Medical School, Japan","institution_ids":["https://openalex.org/I163770644"]},{"raw_affiliation_string":"Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan","institution_ids":["https://openalex.org/I163770644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113574247","display_name":"Shigetoshi Kuroda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigetoshi Kuroda","raw_affiliation_strings":["Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan","institution_ids":["https://openalex.org/I163770644"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052610862","display_name":"Saburo Otsuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Saburo Otsuki","raw_affiliation_strings":["Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan","institution_ids":["https://openalex.org/I163770644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5009599515"],"corresponding_institution_ids":["https://openalex.org/I163770644"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":1.5342,"has_fulltext":false,"cited_by_count":96,"citation_normalized_percentile":{"value":0.79374218,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"296","issue":"2","first_page":"123","last_page":"128"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.02160000056028366,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sigma-receptor-antagonists","display_name":"sigma receptor antagonists","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cocaine-sensitization","display_name":"cocaine sensitization","score":0.765999972820282},{"id":"https://openalex.org/keywords/bmy-14802","display_name":"BMY 14802","score":0.9359999895095825},{"id":"https://openalex.org/keywords/rimcazole","display_name":"rimcazole","score":0.996999979019165},{"id":"https://openalex.org/keywords/psychostimulant-sensitization","display_name":"psychostimulant sensitization","score":0.828000009059906},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.7820000052452087},{"id":"https://openalex.org/keywords/locomotor-hyperactivity","display_name":"locomotor hyperactivity","score":0.8009999990463257},{"id":"https://openalex.org/keywords/schizophrenia-model","display_name":"schizophrenia model","score":0.6169999837875366}],"concepts":[{"id":"https://openalex.org/C2776217527","wikidata":"https://www.wikidata.org/wiki/Q944828","display_name":"Sensitization","level":2,"score":0.7335150241851807},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5120678544044495},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4407111406326294},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3529728651046753},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34805458784103394},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.316692978143692},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2505677342414856},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20195195078849792}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0014-2999(95)00693-1","doi":"https://doi.org/10.1016/0014-2999(95)00693-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(95)00693-1","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:8838447","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8838447","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324071","display_name":"Mitsui and Company","ror":"https://ror.org/05tm9j755"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W80940727","https://openalex.org/W1886668162","https://openalex.org/W1968248600","https://openalex.org/W1985708443","https://openalex.org/W1986807349","https://openalex.org/W1996751433","https://openalex.org/W2008670721","https://openalex.org/W2012671027","https://openalex.org/W2023900408","https://openalex.org/W2031647610","https://openalex.org/W2039323107","https://openalex.org/W2046516880","https://openalex.org/W2050691698","https://openalex.org/W2061633232","https://openalex.org/W2066773748","https://openalex.org/W2067200835","https://openalex.org/W2067901635","https://openalex.org/W2068454440","https://openalex.org/W2078309011","https://openalex.org/W2086844246","https://openalex.org/W2088259526","https://openalex.org/W2092021906","https://openalex.org/W2100321683","https://openalex.org/W2127749802","https://openalex.org/W2128754068","https://openalex.org/W2242199368","https://openalex.org/W2419152593","https://openalex.org/W2442444099","https://openalex.org/W3204549479","https://openalex.org/W4319293053","https://openalex.org/W6652666796","https://openalex.org/W6665744813","https://openalex.org/W6679097247"],"related_works":["https://openalex.org/W3175430652","https://openalex.org/W1996751433","https://openalex.org/W1986134784","https://openalex.org/W2342269370","https://openalex.org/W2073704786","https://openalex.org/W2092021906","https://openalex.org/W2110491883","https://openalex.org/W2085519675","https://openalex.org/W2066346996","https://openalex.org/W2313868102"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}